THERAPEUTIC DRUG MONITORING IN PEDIATRIC HEART TRANSPLANT PATIENTS RECEIVING MYCOPHENOLATE MOFETIL.

被引：0
|
作者：
Plumage, E. F. [1 ]
Illamola, S. M. [1 ]
Balch, A. H. [1 ]
Sherwin, C. M. [1 ]
机构：
[1] Univ Utah, Salt Lake City, UT USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PI-126
引用
收藏
页码：S47 / S47
页数：1
相关论文
共 50 条
  • [21] Oral ulcers in kidney transplant recipients treated with sirolimus and mycophenolate mofetil.
    van Gelder, T
    ter Meulen, CG
    Hené, R
    Weimar, W
    Hoitsma, A
    TRANSPLANTATION, 2003, 75 (06) : 788 - 791
  • [22] Efficacy and Safety of Basiliximab in Pediatric Renal Transplant Patients Receiving Cyclosporine, Mycophenolate Mofetil, and Steroids
    Offner, Gisela
    Toenshoff, Burkhard
    Hoecker, Britta
    Krauss, Manuela
    Bulla, Monika
    Cochat, Pierre
    Fehrenbach, Henry
    Fischer, Wolfgang
    Foulard, Michel
    Hoppe, Bernd
    Hoyer, Peter F.
    Jungraithmayr, Therese C.
    Klaus, Guenter
    Latta, Kay
    Leichter, Heinz
    Mihatsch, Michael J.
    Misselwitz, Joachim
    Montoya, Carmen
    Mueller-Wiefel, Dirk E.
    Neuhaus, Thomas J.
    Pape, Lars
    Querfeld, Uwe
    Plank, Christian
    Schwarke, Dieter
    Wygoda, Simone
    Zimmerhackl, Lothar B.
    TRANSPLANTATION, 2008, 86 (09) : 1241 - 1248
  • [23] The compelling case for therapeutic drug monitoring of mycophenolate mofetil therapy
    Guido Filler
    Ana Catalina Alvarez-Elías
    Christopher McIntyre
    Mara Medeiros
    Pediatric Nephrology, 2017, 32 : 21 - 29
  • [24] The compelling case for therapeutic drug monitoring of mycophenolate mofetil therapy
    Filler, Guido
    Catalina Alvarez-Elias, Ana
    McIntyre, Christopher
    Medeiros, Mara
    PEDIATRIC NEPHROLOGY, 2017, 32 (01) : 21 - 29
  • [25] Drug interaction between mycophenolate mofetil and tacrolimus detectable within therapeutic mycophenolic acid monitoring in renal transplant patients
    Hübner, GI
    Eismann, R
    Sziegoleit, W
    THERAPEUTIC DRUG MONITORING, 1999, 21 (05) : 536 - 539
  • [26] The rationale for and limitations of therapeutic drug monitoring for mycophenolate mofetil in transplantation
    van Gelder, T
    Shaw, LM
    TRANSPLANTATION, 2005, 80 (02) : S244 - S253
  • [27] Investigation of the therapeutic drug monitoring of mycophenolate mofetil in multi-drug immunosuppressant therapy in renal transplant.
    Uchida, K
    Katayama, A
    Goto, N
    Haba, T
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 184 - 184
  • [28] Pharmacokinetics of mycophenolate mofetil in eight pediatric renal transplant patients
    Aigrain, EJ
    Shaghaghi, EK
    Baudouin, V
    Popon, M
    Loirat, C
    TRANSPLANTATION PROCEEDINGS, 2000, 32 (02) : 388 - 390
  • [29] Comparison of the Emit immunoassay with HPLC for therapeutic drug monitoring of mycophenolic acid in pediatric renal-transplant recipients on mycophenolate mofetil therapy
    Weber, LT
    Shipkova, M
    Armstrong, VW
    Wagner, N
    Schütz, E
    Mehls, O
    Zimmerhackl, LB
    Oellerich, M
    Tönshoff, B
    CLINICAL CHEMISTRY, 2002, 48 (03) : 517 - 525
  • [30] Gastrointestinal medication use and costs in heart transplant recipients receiving mycophenolate mofetil
    Legorreta, A. P.
    Gilmore, A. S.
    Marehbian, J.
    Naujoks, C.
    Kilburg, A.
    VALUE IN HEALTH, 2006, 9 (06) : A242 - A243
12345